Inhibiting PI3K/Akt pathway increases DNA damage of cervical carcinoma HeLa cells by drug radiosensitization

Abstract

This study examined the role of PI3K/Akt pathway in radiosensitization of DNA damage of cervical carcinoma cells. The 50% inhibition concentration (IC₅₀) of cisplatin and docetaxel in HeLa cells was detected by Mono-nuclear cell direct cytotoxicity assay (MTT) in vitro. HeLa cells were treated by cisplatin/docetaxel of 10 percent of IC₂₀ alone or combined with LY294002 for 24 h, and then radiated by different doses of X-ray. The cell survival ratio was obtained by means of clone formation. One-hit multi-target model was fitted to the cell survival curve to calculate dose quasithreshold (Dq), mean lethal dose (D₀), 2Gy survival fraction (SF₂) and sensitization enhancement ratio (SER). The pAkt and total Akt expression was detected by Western blotting and DNA damage by neutro-comet electrophoresis. The HeLa cells were randomly divided into 7 groups in terms of different treatments: Control; radiation treatment (RT) group; LY294002+RT group; cisplatin+RT group; docetaxel+RT group; LY294002+cisplatin+RT group; LY294002+docetaxel+RT group. The apoptosis ratio of each group was measured by flow cytometry. The results showed that docetaxel and cisplatin significantly enhanced the phosphorylation of Akt in radiation-treated HeLa cells. The Dq, D₀ and SF2 in LY294002-contained groups were lower than those in docetaxel or cisplatin+RT group. The SER in the LY294002+docetaxel+RT group was 1.35 times that of the docetaxel+RT group, and that in the LY294002+cisplatin+RT group 1.26 times that of the cisplatin+RT group. The Comet electrophoresis showed that tail distance in the LY294002+cisplatin+RT group or LY294002+docetaxel+ RT group was longer than in the cisplatin+RT group or docetaxel+RT group. The apoptosis ratio in the LY294002+cisplatin+RT group or LY294002+docetaxel +RT group was higher than in the cisplatin+RT group or docetaxel+RT group. It was concluded that inhibiting PI3K/Akt pathway can increase the effect of docetaxel and cisplatin on the radiosensitivity of HeLa cells and DNA damage resulted from radiation.

Keywords

cervical carcinoma / PI3K/Akt pathway / radiosensitization / LY294002 / docetaxel / cisplatin / DNA damage

References

[1] JinZ.H., KurosuT., YamaguchiM., et al.. Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis. Oncogene, 2005, 24(12): 1973-1981

[2] ChengJ.Q., LindsleyC.W., ChengG.Z., et al.. The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene, 2005, 24(50): 7482-7492

[3] OpelD., WesthoffM.A., BenderA., et al.. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis. Cancer Res, 2008, 68(15): 6271-6280

[4] OkumuraE., FukuharaT., YoshidaH., et al.. Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition. Nat Cell Biol, 2002, 4(2): 111-116

[5] HanR.ZhouT.C., HanR., XuB.. The application of quantitative analysis of drugs’synergetic and antagonism effect. Chemoprevention and pharmacotherapy of tumor, 1991, Beijing, Peking Union Medical College Press: 315-320

[6] TanJ., HallahanD.E.. Growth factor-independent activation of protein kinase B contributes to the inherent resistance of vascular endothelium to radiation-induced apoptotic response. Cancer Res, 2003, 63(22): 7663-7667

[7] KandelE.S., SkeenJ., MajewskiN., et al.. Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Mol Cell Biol, 2002, 22(22): 7831-7841

[8] RiestererO., TenzerA., ZinggD., et al.. Novel radiosensitizers for locally advanced epithelial tumors: inhibition of the PI3K/Akt survival pathway in tumor cells and in tumor-associated endothelial cells as a novel treatment strategy?. Int J Radiat Oncol Biol Phys, 2004, 58(2): 361-368

[9] CordesN., van BeuningenD.. Arrest of human lung fibroblasts in G2 phase after irradiation is regulated by converging phosphatidylinositol-3 kinase and beta1-integrin signaling in vitro. Int J Radiat Oncol Biol Phys, 2004, 58(2): 453-462

[10] KimI.A., BaeS.S., FernandesA., et al.. Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines. Cancer Res, 2005, 65(17): 7902-7910

[11] GuptaA.K., CernigliaG.J., MickR., et al.. Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002. Int J Radiat Oncol Biol Phys, 2003, 56(3): 846-853

[12] LeeD.F., KuoH.P., ChenC.T., et al.. IKKbeta suppression of TSC1 function links the mTOR pathway with insulin resistance. Int J Mol Med, 2008, 22(5): 633-638

[13] SauerS., BrunoL., HertweckA., et al.. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A, 2008, 105(22): 7797-7802

[14] SteinbergR., HarariO.A., LidingtonE.A., et al.. A protein kinase Cepsilon-anti-apoptotic kinase signaling complex protects human vascular endothelial cells against apoptosis through induction of Bcl-2. J Biol Chem, 2007, 282(44): 32288-32297

[15] AzizM.H., NihalM., FuV.X., et al.. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt pathway and Bcl-2 family proteins. Mol Cancer Ther, 2006, 5(5): 1335-1341

[16] ClarkA.S., WestK., StreicherS., et al.. Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol Cancer Ther, 2002, 1(9): 707-717

[17] CanguilhemB., PradinesA., BaudouinC., et al.. RhoB protects human keratinocytes from UVB-induced apoptosis through epidermal growth factor receptor signaling. J Biol Chem, 2005, 280(52): 43257-43263

[18] ShenY., MiF.S.Tumor Radiation Biology, 2002, Beijing, Chinese Medicine Science Press: 52-78

[19] YinW.B., GuX.Z., XuG.Z., et al.Radiation Oncology, 20084th editionBeijing, Chinese Xiehe Medical University Press: 232-239

[20] FairbairnD.W., OliveP.L., O’NeillK.L.. The comet assay: a comprehensive review. Mutat Res, 1995, 339(1): 37-59

[21] SinghN.P., StephensR.E.. Microgel electrophoresis: sensitivity, mechanisms, and DNA electrostretching. Mutat Res, 1997, 383(2): 167-175

[22] OkayasuR., TakakuraK., PooleS., et al.. Radiosensitization of normal human cells by LY294002: Cell killing and the rejoining of DNA and interphase chromosome breaks. J Radiat Res (Tokyo), 2003, 44(4): 329-333

[23] FriedmannB., CaplinM., HartleyJ.A., et al.. Modulation of DNA repair in vitro after treatment with chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib (ZD1839). Clin Cancer Res, 2004, 10(19): 6476-6486